The Pharmaceutical Market: Czech Republic

Publication Date	April 2009
Publisher	Espicom
Product Type	Report
Pages	78
ISBN Number	not applicable
Product Code	ESP00228

Buy this product or for assistance call +44 20 7060 7474

PDF £595.00$975 | €694

FAX Order above formats by FAX

Summary

Espicom's in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Content

EXECUTIVE SUMMARY
Introduction
Pharmaceutical Market Analysis
- Size
- Market Structure
- Generics Sector
- Projections & Outlook
- Imports
- Parallel Imports
- Domestic Manufacturing
- Domestic Production
- GMP compliance
- Trade Associations
- Local Manufacturers
- Farmak
- Glenmark Pharmaceuticals (Medicamenta)
- ICN Czech Republic (VUAB)
- IVAX CR
- Pliva-Lachema
- Spofa
- Zentiva
- Financial Results
- Exports
Pharmaceutical Regulatory Analysis
- Pharmaceutical Regulation
- New EU Rules
- Pharmaceutical Registration/Drug Approval Process
- Clinical trials
- Post marketing surveillance
- Advertising
- Pricing & Reimbursement
- Pricing
- Reimbursement
- Intellectual Property
Pharmaceutical Distribution
- Wholesaling
- Retailing
Healthcare Analysis
- Demographics
- Population
- Birth Rate
- Death Rate
- Infant Mortality
- Life Expectancy at Birth
- Public Health
- Causes of Death
- Incidence of Communicable Diseases
- Incidence of Non-communicable Diseases
- Diabetes
- HIV/AIDS
- Healthcare System
- Health Expenditure
- Healthcare Infrastructure
- Inpatient Analysis
- Healthcare Personnel
DIRECTORY
- Government Organisations
- Trade Associations
Methodology & Sources
List of Tables
- Summary of Key Data Projections, 2009-2014
- Summary of the Czech Pharmaceutical Market, 2009
- Distributed Medicinal Products, 1995-2006
- Distributed Medicinal Products by ATC, 2006
- Market Projections, 2009-2014
- SWOT Analysis of the Czech Pharmaceutical Market, 2009
- Espicom Analysis of the Czech Health Sector, 2009
- Imports of Pharmaceuticals by Category, 2003-2007 (US$000s)
- Import Trends, 2006-2007 (US$000s)
- Leading Suppliers of Raw Materials, 2007 (US$000s)
- Leading Suppliers of Antisera & Vaccines, 2007 (US$000s)
- Leading Suppliers of Medicaments, 2007 (US$000s)
- API Manufacturers with GMP Certificates, January 2009
- AIFP Members, 2009
- CAFF Members, 2009
- Zentiva: Top Brands, 2007 (CZK millions)
- Zentiva Financial Results, 2000-2008
- Pharmaceutical Sales by Region, 2006-2007 (CZK millions)
- Exports of Pharmaceuticals, 2003-2007 (US$000s)
- Export Trends, 2006-2007 (US$000s)
- Leading Destinations, 2007 (US$000s)
- SUKL Drug Registration Activity, 2000-2007
- Pharmacies, 1999-2007
- Summary of Demographic Data, 2007/8
- Projected Population, 2009-2014
- Healthcare Expenditure, 2007
- Projected Health Expenditure, 2009-2014
- Hospitals & Beds, 2007
- Hospital Bed Projections, 2009-2014
- Hospital Activity Trends, 1998-2007
- Projected Number of Physicians, 2009-2014
List of Charts
- Distributed Medicinal Products by ATC, 2006 (CZK billion)